BioCision

Larkspur, United States Founded: 2007 • Age: 19 yrs
Provider of handling, storage and transport solutions for temperature-sensitive biomedical samples and drugs

About BioCision

BioCision is a company based in Larkspur (United States) founded in 2007. BioCision has raised $11.1 million across 4 funding rounds from investors including Brooks Automation, CYWP Fund and Research Corporation Technologies. The company has 48 employees. BioCision operates in a competitive market with competitors including Brooks Automation, Bridge to Life, Hemanext, Atelerix and Cellbox Solutions, among others.

  • Headquarter Larkspur, United States
  • Employees 48
  • Sectors
    Healthcare
  • Website biocision.com
  • Legal Name Biocision Llc
Key Metrics
  • Total Equity Funding
    $11.1M (USD)

    in 4 rounds

  • Investors
  • Employee Count
    48

Funding Insights of BioCision

BioCision has successfully raised a total of $11.1M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $11.1M
  • Total Rounds 4
  • First Round $2.5M

    (Jul 2013)

  • Investors Count 3

All 4 funding rounds of BioCision with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2016–Series A–CYwP Funds
–
Jan 2015$2.75MSeries A––
–
Mar 2014$5.85MSeries A––
–
Jul 2013$2.5MSeries A–Brooks Automation
Valuation history

3 investors in total: 3 institutional.

Investors in BioCision

BioCision has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Brooks Automation, CYWP Fund and Research Corporation Technologies.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Flexible growth capital is provided by CYWP Fund.
–cywpfund.com-
Research Corporation Technologies is engaged in licensing biomedical technologies.
–rctech.comTucson, United States
Vacuum robots for semiconductor wafer handling are developed.
1978brooks.comChelmsford, United States
Premium access

Investor details for BioCision

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of BioCision

264 people are tracked at BioCision (63 in leadership, 7 in board & advisors, 194 in team); the tracked headcount is 48.

NameRoleGroup
Nicole Siegler
Senior Director, Assistant General CounselLeadership
Samir Dilawari
Senior Director Of AccountingLeadership
Nick Garside
Director - Key Account Management - Life Science ProductsLeadership
Derek Stenli
Head Of Corporate Fp&a And Finance OperationsLeadership
Cheryl Morrison
Director, Regional SalesLeadership
Michael Paulo
VP, Chief Information & Digital OfficerLeadership
Ginger Zhou
VP & GM, Genomic ServicesLeadership
Stephen S. Schwartz
President & CEOLeadership
Christopher Mozdzierz
Senior Director & General Manager - Americas RegionLeadership
Rupa Duhra Ark
Senior Director Global Sales Consumables And InstrumentsLeadership
David C. Gray
SVP & Chief Strategy & New Business OfficerLeadership
Shirley Mai
Human Resources Business PartnerLeadership
Yu Zheng
Associate DirectorLeadership
Jeffrey Otto
Senior Business Director, Laboratory ServicesLeadership
Haythem Latif
Sr Director & GM Global NGS & Clinical ServicesLeadership
Rui Fan
Director, Technical Support And Business DevelopmentLeadership
David Pevzner
Senior Director, North America, SalesLeadership
Bill Foss
Director Revenue AccountingLeadership
Rex Wu
Vp/gm APACLeadership
Gloria N.
Human Resources Business PartnerLeadership

244 more people are available in the full profile.

Premium access

Complete people profiles for BioCision

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of BioCision

3 dated milestones of BioCision across 9 years, from founding to its latest funding, stage changes and deals.

  1. Founded BioCision is founded.
  2. Funding First funding round of $2.5M.
  3. Funding Latest funding round, Series A,.

Competitors of BioCision

BioCision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Brooks Automation, Bridge to Life, Hemanext, Atelerix and Cellbox Solutions, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
brooks.com1978Chelmsford, United States–1,928
Vacuum robots for semiconductor wafer handling are developed.
bridgetolife.com2012Columbia, United States$57M–
Cold storage solutions for organ transplant preservation are provided.
hemanext.com2004Lexington, United States$127.57M53
Technologies for blood and product storage are developed.
atelerix.co.uk2017Newcastle Upon Tyne, United Kingdom$2.43M9
Technology for cell storage and transportation is developed.
cellbox-solutions.com2016Lubeck, Germany$6.99M–
Portable devices for cell storage and transport are provided.
coldchaintech.com2001Franklin, United States––
Thermal packaging solutions and cold chain monitoring services are provided.
nectome.com2015San Francisco, United States––
Brain preservation is achieved through chemical fixation and vitrification techniques.
genepoint.cn2015Shanghai, China$48.3M–
Platform for cryostorage and long-term biological preservation is provided.
preanalytix.com2000Hombrechtikon, Switzerland––
Sample collection and storage systems for biomolecules are provided.
Premium access

Detailed competitors of BioCision

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of BioCision

Websites that share an audience with BioCision (biocision.com).

Similar websites

Websites whose visitors overlap most with BioCision. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
stemcellfoundation.net.au
stemcellfoundation.net.au
100%
–#4,896,910–
isscr.org
isscr.org
99%
–#554,046–
nyscf.org
nyscf.org
83%
–#1,266,969–
abnova.com
82%
30.7K#957,320View details
biolegend.com
82%
229.6K#142,656View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 13 similar websites and full traffic analytics for BioCision

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 13 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Similar companies to BioCision

10 companies that operate in the same segment as BioCision (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M––
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B––
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Biological reagents and antibodies are developed for life science research.
1998Cambridge, Cambridgeshire, United KingdomUSD 78.8 M––
Electron microscopy services and microanalysis instruments are provided.
1956Waltham, Massachusetts, United States–USD 44.56 B125,000
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
A platform for sharing and accessing academic research papers is provided.
2008San Francisco, California, United StatesUSD 58.4 M––
Developer of molecular diagnostic testing solutions
1996Sunnyvale, California, United StatesUSD 19.1 MUSD 54.88 M208
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about BioCision

BioCision was founded in 2007 and raised its 1st funding round 6 years after it was founded.

BioCision is headquartered in Larkspur, United States. It is registered at Larkspur, Colorado, United States.

BioCision is a funded company, having raised a total of $11.1M across 4 funding rounds to date. The company's 1st funding round was a Series A of $2.5M, raised on Jul 2013.

BioCision has 48 employees.

BioCision develops and supplies cell cryopreservation products, systems, and solutions. Products include CoolCell Freezing Containers, ThawSTAR Automated Cell Thawing Systems, BioT Temperature Stability Systems, CoolRack Tube Cooling Modules, CoolSink Plate Cooling Modules, ThermalTray Cooling Platforms, TruCool Hinged CryoBoxes, TruCool Leak-Proof Cryogenic Vials and TruCool Lab Accessories. Its products are used by institutions in the biotech, pharmaceutical, clinical, diagnostic, academic and government scientific community.

BioCision's top competitors include Brooks Automation, Hemanext and Bridge to Life.

BioCision has 3 investors. Key investors include Brooks Automation, CYWP Fund, and Research Corporation Technologies.

BioCision operates through Biocision Llc.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available